The stock of Acutus Medical Inc (AFIB) has seen a 9.34% increase in the past week, with a 0.86% gain in the past month, and a -11.03% decrease in the past quarter. The volatility ratio for the week is 6.58%, and the volatility levels for the past 30 days are at 10.38% for AFIB. The simple moving average for the past 20 days is -4.51% for AFIB’s stock, with a -57.61% simple moving average for the past 200 days.
Is It Worth Investing in Acutus Medical Inc (NASDAQ: AFIB) Right Now?
The 36-month beta value for AFIB is also noteworthy at 0.21. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for AFIB is 18.94M, and at present, short sellers hold a 4.46% of that float. The average trading volume of AFIB on April 12, 2024 was 2.34M shares.
AFIB) stock’s latest price update
The stock price of Acutus Medical Inc (NASDAQ: AFIB) has jumped by 7.88 compared to previous close of 0.16. Despite this, the company has seen a gain of 9.34% in its stock price over the last five trading days. Benzinga reported 2023-11-17 that The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Analysts’ Opinion of AFIB
Goldman, on the other hand, stated in their research note that they expect to see AFIB reach a price target of $10. The rating they have provided for AFIB stocks is “Neutral” according to the report published on October 22nd, 2021.
Canaccord Genuity gave a rating of “Buy” to AFIB, setting the target price at $18 in the report published on July 15th of the previous year.
AFIB Trading at -8.15% from the 50-Day Moving Average
After a stumble in the market that brought AFIB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.79% of loss for the given period.
Volatility was left at 10.38%, however, over the last 30 days, the volatility rate increased by 6.58%, as shares sank -1.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.61% lower at present.
During the last 5 trading sessions, AFIB rose by +9.34%, which changed the moving average for the period of 200-days by -80.15% in comparison to the 20-day moving average, which settled at $0.1849. In addition, Acutus Medical Inc saw -12.48% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AFIB
Current profitability levels for the company are sitting at:
- -1.64 for the present operating margin
- -0.44 for the gross margin
The net margin for Acutus Medical Inc stands at -11.44. The total capital return value is set at -0.33. Equity return is now at value -73.28, with -32.90 for asset returns.
Based on Acutus Medical Inc (AFIB), the company’s capital structure generated 1.02 points at debt to capital in total, while cash flow to debt ratio is standing at -1.64. The debt to equity ratio resting at -43.78. The interest coverage ratio of the stock is -2.07.
Currently, EBITDA for the company is -13.49 million with net debt to EBITDA at -1.39. When we switch over and look at the enterprise to sales, we see a ratio of 3.43. The receivables turnover for the company is 0.63for trailing twelve months and the total asset turnover is 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.92.
Conclusion
In summary, Acutus Medical Inc (AFIB) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
